Why the study?
Preclinical cardioprotective interventions are often limited to small animal models that fail to translate to large animal models and clinical practice.
Large animal models are essential for translating cardioprotective strategies for ischemia-reperfusion injury, despite challenges in mimicking human disease and anatomical differences.
Review of large animal IRI models underscores translational barriers; leaves open optimal standardization for clinical cardioprotection.
Large animal models of cardiac ischemia-reperfusion are critical for evaluation of the efficacy of cardioprotective interventions prior to clinical translation. Nonetheless, current cardioprotective strategies/interventions formulated in preclinical cardiovascular research are often limited to small animal models, which are not transferable or reproducible in large animal models due to different factors such as: (i) complex and varied features of human ischemic cardiac disease (ICD), which are challenging to mimic in animal models, (ii) significant differences in surgical techniques applied, and (iii) differences in cardiovascular anatomy and physiology between small versus large animals. This article highlights the advantages and disadvantages of different large animal models of preclinical cardiac ischemic reperfusion injury (IRI), as well as the different methods used to induce and assess IRI, and the obstacles faced in using large animals for translational research in the settings of cardiac IR.
No takes yet. Share an insight, caveat, or question.
Rahman et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: